Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy
暂无分享,去创建一个
V. Hombach | N. Merkle | J. Torzewski | O. Grebe | M. Kochs | T. Nusser | O. Zimmermann | M. Bienek-Ziolkowski | M. Bienek‐Ziolkowski
[1] V. Hombach,et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. , 2005, International journal of cardiology.
[2] Heather Kalish,et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.
[3] Udo Sechtem,et al. Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.
[4] Elliot R. McVeigh,et al. Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells , 2003, Circulation.
[5] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[6] H. Schultheiss,et al. Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .
[7] Jan Bogaert,et al. Late Myocardial Enhancement in Hypertrophic Cardiomyopathy with Contrast-Enhanced MR Imaging , 2003 .
[8] Katherine C. Wu,et al. Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction , 2002, Circulation.
[9] V. Hombach,et al. Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes. , 2002, The American journal of pathology.
[10] M. Małecki,et al. Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domains , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Strauer,et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. , 2000, Journal of the American College of Cardiology.
[12] O Strohm,et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. , 1998, Circulation.
[13] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[14] H. Schultheiss,et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. , 1996, Heart.
[15] T. Martino,et al. Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.
[16] C. Higgins,et al. Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging. , 1990, Radiology.
[17] R. Brasch,et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. , 1984, AJR. American journal of roentgenology.